サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1353114

C反応性タンパク質検査の世界市場規模、シェア、産業動向分析レポート：用途別、アッセイタイプ別、エンドユーザー別、地域別展望と予測、2023年～2030年

Global C-reactive Protein Testing Market Size, Share & Industry Trends Analysis Report By Application, By Assay Type, By End User (Hospitals & Clinics, Diagnostic Laboratories, and Others), By Regional Outlook and Forecast, 2023 - 2030
出版日: | 発行: KBV Research | ページ情報: 英文 268 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
C反応性タンパク質検査の世界市場規模、シェア、産業動向分析レポート：用途別、アッセイタイプ別、エンドユーザー別、地域別展望と予測、2023年～2030年
出版日: 2023年08月31日
発行: KBV Research
ページ情報: 英文 268 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

C反応性タンパク質検査市場規模は、予測期間中にCAGR 2.8％の市場成長率で上昇し、2030年までに35億米ドルに達すると予測されています。

さらに、COVID-19の発生は、C反応性タンパク質検査市場を支援しました。COVID-19と診断された患者に対する病院の収容力を高めるため、世界中の多くの診療所や病院が再編されました。C反応性蛋白（CRP）は、重症のCOVID-19患者の間で有意に上昇する重要な指標として観察されました。CRPの濃度は炎症が治まると低下するため、COVID-19の重症度や肺病変を評価する貴重なマーカーと考えられました。その結果、COVID-19の大流行時にCRP検査が急増し、市場成長率が大幅に上昇しました。

しかし、CRPは炎症の包括的な指標です。そのため、この検査はあらゆる病気を正確に診断するには不十分です。したがって、自己完結的な診断検査ではないという事実が、この市場の成長を妨げる可能性があります。磁気共鳴画像法（MRI）、コンピューター断層撮影法（CT）、超音波検査などの画像検査は、炎症組織を可視化し、関節炎、感染症、炎症性腸疾患などの診断に役立ちます。アクセス可能な代替疾患診断技術は数多くあるため、市場の拡大は消費者の人気によって制限される可能性があります。

アプリケーションの展望

用途別に見ると、市場は糖尿病、関節リウマチ、心血管疾患、炎症性腸疾患、その他に細分化されます。2022年の市場では、関節リウマチ分野が突出した収益シェアを予測しています。CRP値の上昇は、他の臨床検査や臨床評価とともに関節リウマチの診断に役立ちます。CRP値の経時的な低下は、治療法がRA関連の炎症を効果的に抑制していることを示すことが多いです。

アッセイタイプの展望

アッセイタイプ別に見ると、市場は酵素免疫吸着測定法（ELISA）、化学発光免疫測定法（CLIA）、免疫比濁測定法、その他に区分されます。酵素結合免疫吸着測定法（ELISA）セグメントは、2022年の市場でかなりの収益シェアを獲得しました。サンプル中のCRPの正確な濃度はELISAによって測定され、定量データが得られます。これにより、経時的な変化を正確にモニタリングすることが可能になり、ヘルスケア専門家による疾患活動性と治療反応の評価に役立ちます。ELISA法はCRPに非常に特異的に設計できるため、血液中の他の物質との交差反応によって検査結果が影響を受ける可能性は低いです。

エンドユーザーの展望

エンドユーザーによって、市場は病院・診療所、診断検査室、その他に分けられます。診断検査室セグメントは2022年の市場成長率が顕著です。診断検査室は、正確な診断、治療計画、動物の疼痛の継続的モニタリングの基盤を提供するため、獣医疼痛管理には不可欠です。動物の生活の質と福祉を向上させる上で、その役割は誇張しすぎることはなく、獣医師にとってもペットの飼い主にとっても貴重な資源です。

地域別展望

地域別に見ると、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。2022年には、北米地域が市場で最も高い収益シェアを記録しました。ポイントオブケア検査の利便性と迅速性が、同地域の成長動向となっています。POCTによるCRP検査の迅速な結果は、迅速な診断と治療に役立ちます。北米の市場は、CRP検査の精度、有効性、手頃な価格を改善した技術の進歩によって牽引されると予測されます。予測期間中、北米の市場は、炎症性疾患の有病率の増加、不健康なライフスタイル、炎症性疾患の早期発見のための新しい検査キットやソリューションの開拓によって牽引されると予測されます。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場範囲
  • セグメンテーション
  • 調査手法

第2章 市場の概要

  • 主なハイライト

第3章 市場概要

  • イントロダクション
    • 概要
      • 市場構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場抑制要因
  • ポーターのファイブフォース分析

第4章 世界のC反応性タンパク質検査市場：用途別

  • 世界の心血管疾患市場：地域別
  • 世界の炎症性腸疾患市場：地域別
  • 世界の関節リウマチ市場：地域別
  • 世界の糖尿病市場：地域別
  • 世界のその他の市場：地域別

第5章 世界のC反応性タンパク質検査市場：アッセイタイプ別

  • 世界の免疫比濁分析市場：地域別
  • 世界の酵素免疫測定法（ELISA）市場：地域別
  • 世界の化学発光免疫測定法（CLIA）市場：地域別
  • 世界のその他の市場：地域別

第6章 世界のC反応性タンパク質検査市場：エンドユーザー別

  • 世界の病院およびクリニック市場：地域別
  • 世界の診断研究所市場：地域別
  • 世界のその他の市場：地域別

第7章 世界のC反応性タンパク質検査市場：地域別

  • 北米
    • 北米の市場：国別
      • 米国
      • カナダ
      • メキシコ
      • その他北米地域
  • 欧州
    • 欧州の市場：国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州地域
  • アジア太平洋
    • アジア太平洋の市場：国別
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋地域
  • ラテンアメリカ・中東・アフリカ
    • ラテンアメリカ・中東・アフリカの市場：国別
      • ブラジル
      • アルゼンチン
      • アラブ首長国連邦
      • サウジアラビア
      • 南アフリカ
      • ナイジェリア
      • その他ラテンアメリカ・中東・アフリカ地域

第8章 企業プロファイル

  • Danaher Corporation
  • F Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc
  • Horiba Ltd
  • Randox Laboratories Limited
  • Zoetis, Inc
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings
  • Merck KGaA

第9章 C反応性タンパク質検査市場における勝利の必須条件

図表

LIST OF TABLES

  • TABLE 1 Global C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 2 Global C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 3 Global C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 4 Global C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 5 Global Cardiovascular Disease Market by Region, 2019 - 2022, USD Million
  • TABLE 6 Global Cardiovascular Disease Market by Region, 2023 - 2030, USD Million
  • TABLE 7 Global Inflammatory Bowel Disease Market by Region, 2019 - 2022, USD Million
  • TABLE 8 Global Inflammatory Bowel Disease Market by Region, 2023 - 2030, USD Million
  • TABLE 9 Global Rheumatoid Arthritis Market by Region, 2019 - 2022, USD Million
  • TABLE 10 Global Rheumatoid Arthritis Market by Region, 2023 - 2030, USD Million
  • TABLE 11 Global Diabetes Market by Region, 2019 - 2022, USD Million
  • TABLE 12 Global Diabetes Market by Region, 2023 - 2030, USD Million
  • TABLE 13 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 14 Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 15 Global C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 16 Global C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 17 Global Immunoturbidimetric Assays Market by Region, 2019 - 2022, USD Million
  • TABLE 18 Global Immunoturbidimetric Assays Market by Region, 2023 - 2030, USD Million
  • TABLE 19 Global Enzyme-linked Immunosorbent Assay (ELISA) Market by Region, 2019 - 2022, USD Million
  • TABLE 20 Global Enzyme-linked Immunosorbent Assay (ELISA) Market by Region, 2023 - 2030, USD Million
  • TABLE 21 Global Chemiluminescence Immunoassay (CLIA) Market by Region, 2019 - 2022, USD Million
  • TABLE 22 Global Chemiluminescence Immunoassay (CLIA) Market by Region, 2023 - 2030, USD Million
  • TABLE 23 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 24 Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 25 Global C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 26 Global C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 27 Global Hospitals & Clinics Market by Region, 2019 - 2022, USD Million
  • TABLE 28 Global Hospitals & Clinics Market by Region, 2023 - 2030, USD Million
  • TABLE 29 Global Diagnostic Laboratories Market by Region, 2019 - 2022, USD Million
  • TABLE 30 Global Diagnostic Laboratories Market by Region, 2023 - 2030, USD Million
  • TABLE 31 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 32 Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 33 Global C-reactive Protein Testing Market by Region, 2019 - 2022, USD Million
  • TABLE 34 Global C-reactive Protein Testing Market by Region, 2023 - 2030, USD Million
  • TABLE 35 North America C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 36 North America C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 37 North America C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 38 North America C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 39 North America Cardiovascular Disease Market by Country, 2019 - 2022, USD Million
  • TABLE 40 North America Cardiovascular Disease Market by Country, 2023 - 2030, USD Million
  • TABLE 41 North America Inflammatory Bowel Disease Market by Country, 2019 - 2022, USD Million
  • TABLE 42 North America Inflammatory Bowel Disease Market by Country, 2023 - 2030, USD Million
  • TABLE 43 North America Rheumatoid Arthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 44 North America Rheumatoid Arthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 45 North America Diabetes Market by Country, 2019 - 2022, USD Million
  • TABLE 46 North America Diabetes Market by Country, 2023 - 2030, USD Million
  • TABLE 47 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 48 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 49 North America C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 50 North America C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 51 North America Immunoturbidimetric Assays Market by Country, 2019 - 2022, USD Million
  • TABLE 52 North America Immunoturbidimetric Assays Market by Country, 2023 - 2030, USD Million
  • TABLE 53 North America Enzyme-linked Immunosorbent Assay (ELISA) Market by Country, 2019 - 2022, USD Million
  • TABLE 54 North America Enzyme-linked Immunosorbent Assay (ELISA) Market by Country, 2023 - 2030, USD Million
  • TABLE 55 North America Chemiluminescence Immunoassay (CLIA) Market by Country, 2019 - 2022, USD Million
  • TABLE 56 North America Chemiluminescence Immunoassay (CLIA) Market by Country, 2023 - 2030, USD Million
  • TABLE 57 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 58 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 59 North America C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 60 North America C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 61 North America Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 62 North America Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 63 North America Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
  • TABLE 64 North America Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
  • TABLE 65 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 66 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 67 North America C-reactive Protein Testing Market by Country, 2019 - 2022, USD Million
  • TABLE 68 North America C-reactive Protein Testing Market by Country, 2023 - 2030, USD Million
  • TABLE 69 US C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 70 US C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 71 US C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 72 US C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 73 US C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 74 US C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 75 US C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 76 US C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 77 Canada C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 78 Canada C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 79 Canada C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 80 Canada C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 81 Canada C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 82 Canada C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 83 Canada C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 84 Canada C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 85 Mexico C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 86 Mexico C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 87 Mexico C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 88 Mexico C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 89 Mexico C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 90 Mexico C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 91 Mexico C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 92 Mexico C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 93 Rest of North America C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 94 Rest of North America C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 95 Rest of North America C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 96 Rest of North America C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 97 Rest of North America C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 98 Rest of North America C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 99 Rest of North America C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 100 Rest of North America C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 101 Europe C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 102 Europe C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 103 Europe C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 104 Europe C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 105 Europe Cardiovascular Disease Market by Country, 2019 - 2022, USD Million
  • TABLE 106 Europe Cardiovascular Disease Market by Country, 2023 - 2030, USD Million
  • TABLE 107 Europe Inflammatory Bowel Disease Market by Country, 2019 - 2022, USD Million
  • TABLE 108 Europe Inflammatory Bowel Disease Market by Country, 2023 - 2030, USD Million
  • TABLE 109 Europe Rheumatoid Arthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 110 Europe Rheumatoid Arthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 111 Europe Diabetes Market by Country, 2019 - 2022, USD Million
  • TABLE 112 Europe Diabetes Market by Country, 2023 - 2030, USD Million
  • TABLE 113 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 114 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 115 Europe C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 116 Europe C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 117 Europe Immunoturbidimetric Assays Market by Country, 2019 - 2022, USD Million
  • TABLE 118 Europe Immunoturbidimetric Assays Market by Country, 2023 - 2030, USD Million
  • TABLE 119 Europe Enzyme-linked Immunosorbent Assay (ELISA) Market by Country, 2019 - 2022, USD Million
  • TABLE 120 Europe Enzyme-linked Immunosorbent Assay (ELISA) Market by Country, 2023 - 2030, USD Million
  • TABLE 121 Europe Chemiluminescence Immunoassay (CLIA) Market by Country, 2019 - 2022, USD Million
  • TABLE 122 Europe Chemiluminescence Immunoassay (CLIA) Market by Country, 2023 - 2030, USD Million
  • TABLE 123 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 124 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 125 Europe C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 126 Europe C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 127 Europe Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 128 Europe Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 129 Europe Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
  • TABLE 130 Europe Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
  • TABLE 131 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 132 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 133 Europe C-reactive Protein Testing Market by Country, 2019 - 2022, USD Million
  • TABLE 134 Europe C-reactive Protein Testing Market by Country, 2023 - 2030, USD Million
  • TABLE 135 Germany C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 136 Germany C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 137 Germany C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 138 Germany C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 139 Germany C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 140 Germany C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 141 Germany C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 142 Germany C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 143 UK C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 144 UK C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 145 UK C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 146 UK C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 147 UK C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 148 UK C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 149 UK C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 150 UK C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 151 France C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 152 France C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 153 France C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 154 France C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 155 France C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 156 France C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 157 France C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 158 France C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 159 Russia C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 160 Russia C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 161 Russia C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 162 Russia C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 163 Russia C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 164 Russia C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 165 Russia C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 166 Russia C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 167 Spain C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 168 Spain C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 169 Spain C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 170 Spain C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 171 Spain C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 172 Spain C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 173 Spain C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 174 Spain C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 175 Italy C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 176 Italy C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 177 Italy C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 178 Italy C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 179 Italy C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 180 Italy C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 181 Italy C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 182 Italy C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 183 Rest of Europe C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 184 Rest of Europe C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 185 Rest of Europe C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 186 Rest of Europe C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 187 Rest of Europe C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 188 Rest of Europe C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 189 Rest of Europe C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 190 Rest of Europe C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 191 Asia Pacific C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 192 Asia Pacific C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 193 Asia Pacific C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 194 Asia Pacific C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 195 Asia Pacific Cardiovascular Disease Market by Country, 2019 - 2022, USD Million
  • TABLE 196 Asia Pacific Cardiovascular Disease Market by Country, 2023 - 2030, USD Million
  • TABLE 197 Asia Pacific Inflammatory Bowel Disease Market by Country, 2019 - 2022, USD Million
  • TABLE 198 Asia Pacific Inflammatory Bowel Disease Market by Country, 2023 - 2030, USD Million
  • TABLE 199 Asia Pacific Rheumatoid Arthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 200 Asia Pacific Rheumatoid Arthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 201 Asia Pacific Diabetes Market by Country, 2019 - 2022, USD Million
  • TABLE 202 Asia Pacific Diabetes Market by Country, 2023 - 2030, USD Million
  • TABLE 203 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 204 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 205 Asia Pacific C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 206 Asia Pacific C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 207 Asia Pacific Immunoturbidimetric Assays Market by Country, 2019 - 2022, USD Million
  • TABLE 208 Asia Pacific Immunoturbidimetric Assays Market by Country, 2023 - 2030, USD Million
  • TABLE 209 Asia Pacific Enzyme-linked Immunosorbent Assay (ELISA) Market by Country, 2019 - 2022, USD Million
  • TABLE 210 Asia Pacific Enzyme-linked Immunosorbent Assay (ELISA) Market by Country, 2023 - 2030, USD Million
  • TABLE 211 Asia Pacific Chemiluminescence Immunoassay (CLIA) Market by Country, 2019 - 2022, USD Million
  • TABLE 212 Asia Pacific Chemiluminescence Immunoassay (CLIA) Market by Country, 2023 - 2030, USD Million
  • TABLE 213 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 214 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 215 Asia Pacific C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 216 Asia Pacific C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 217 Asia Pacific Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 218 Asia Pacific Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 219 Asia Pacific Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
  • TABLE 220 Asia Pacific Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
  • TABLE 221 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 222 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 223 Asia Pacific C-reactive Protein Testing Market by Country, 2019 - 2022, USD Million
  • TABLE 224 Asia Pacific C-reactive Protein Testing Market by Country, 2023 - 2030, USD Million
  • TABLE 225 China C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 226 China C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 227 China C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 228 China C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 229 China C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 230 China C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 231 China C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 232 China C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 233 Japan C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 234 Japan C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 235 Japan C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 236 Japan C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 237 Japan C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 238 Japan C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 239 Japan C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 240 Japan C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 241 India C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 242 India C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 243 India C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 244 India C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 245 India C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 246 India C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 247 India C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 248 India C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 249 South Korea C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 250 South Korea C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 251 South Korea C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 252 South Korea C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 253 South Korea C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 254 South Korea C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 255 South Korea C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 256 South Korea C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 257 Singapore C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 258 Singapore C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 259 Singapore C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 260 Singapore C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 261 Singapore C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 262 Singapore C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 263 Singapore C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 264 Singapore C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 265 Malaysia C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 266 Malaysia C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 267 Malaysia C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 268 Malaysia C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 269 Malaysia C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 270 Malaysia C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 271 Malaysia C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 272 Malaysia C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 273 Rest of Asia Pacific C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 274 Rest of Asia Pacific C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 275 Rest of Asia Pacific C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 276 Rest of Asia Pacific C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 277 Rest of Asia Pacific C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 278 Rest of Asia Pacific C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 279 Rest of Asia Pacific C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 280 Rest of Asia Pacific C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
目次

The Global C-Reactive Protein Testing Market size is expected to reach $3.5 billion by 2030, rising at a market growth of 2.8% CAGR during the forecast period.

Chronic conditions like cardiovascular conditions are associated with high C-reactive protein levels. Therefore, Cardiovascular Disease segment would capture more than 56% share of the market by 2030. The primary factor advancing the expansion of the segment is the rise in the prevalence of CVDs. CRP is a critical marker for identifying CVD by determining the probability of atherosclerosis. Patients with CVDs often have elevated CRP levels, and assays may identify even the lowest amounts of CRP. As a result, the use of CRP testing for the early diagnosis of cardiovascular disorders has dramatically increased, which has caused this segment's revenue to grow throughout the projection period. Some of the Factors impacting the market are increase prevalence of inflammatory diseases, increasing demand for point-of-care testing, and alternative disease-testing techniques are accessible.

This market is projected to expand as inflammatory diseases grow more widespread. The liver produces CRP, an acute-phase protein, in response to tissue damage, infection, or inflammation. The existence of inflammation in the body, which is associated with various illnesses such as cardiovascular disease, rheumatoid arthritis, inflammatory bowel disease, and several types of cancers, may be indicated by elevated levels of CRP in the blood. Overall, the prevalence of inflammatory diseases is on the rise, and CRP testing methods have advanced in technology, which is expected to propel the market. Moreover, POCT is a medical examination carried out near the patient rather than in a centralized laboratory and offers immediate results. POCT for CRP makes testing fast and simple in primary care settings, ERs, and other point-of-care settings, which is especially beneficial for patients who need diagnosis and treatment immediately. This market is predicted to be boosted by increased demand for POCT since it offers a cost-effective and accessible alternative for laboratory testing, which may benefit patients' outcomes and lower healthcare expenditures.

Additionally, The COVID-19 outbreak assisted the market for C-reactive protein testing. In order to boost hospital capacity for patients diagnosed with COVID-19, many clinics and hospitals worldwide were restructured. C-reactive protein (CRP) was observed as a crucial measure that significantly rose among people with severe COVID-19. It was considered a valuable marker for assessing the severity of the disease and lung lesions because its concentration decreases when the inflammatory stages end and the patient heals. As a result, CRP testing surged during the COVID-19 pandemic, considerably increasing market growth.

However, C-reactive protein is a comprehensive indicator of inflammation. As a result, this test is inadequate for accurately diagnosing any illness. Therefore, the fact that it is not a self-sufficient diagnostic test could prevent this market from growing. Imaging studies like magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound can visualize inflamed tissues and help diagnose conditions such as arthritis, infections, and inflammatory bowel disease. As there are numerous alternative disease diagnostic technologies accessible, the market's expansion might be restricted by their popularity among consumers.

Application Outlook

Based on application, the market is fragmented into diabetes, rheumatoid arthritis, cardiovascular disease, inflammatory bowel disease, and others. The rheumatoid arthritis segment projected a prominent revenue share in the market in 2022. Elevated CRP levels, along with other laboratory tests and clinical evaluations, can aid in diagnosing rheumatoid arthritis, even though no single test can confirm the diagnosis. CRP level reduction over time often indicates that a treatment technique effectively controls RA-related inflammation.

Assay Type Outlook

By assay type, the market is segmented into enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), immunoturbidimetric assays, and others. The enzyme-linked immunosorbent assay (ELISA) segment acquired a substantial revenue share in the market in 2022. The precise concentration of CRP in a sample is measured by ELISA, which produces quantitative data. This enables precise monitoring of changes over time and aids in evaluating disease activity and treatment response by healthcare professionals. Since ELISA assays can be designed to be very specific to CRP, there is a low probability that the test results will be affected by any cross-reactivity with other substances in the blood.

End User Outlook

based on end user, the market is divided into hospitals & clinics, diagnostic laboratories, and others. The diagnostics laboratories segment witnessed a remarkable growth rate in the market in 2022. Diagnostic laboratories are essential in veterinary pain management as they provide the foundation for accurate diagnosis, treatment planning, and ongoing monitoring of pain in animals. Their role in improving the quality of life and welfare of animals cannot be overstated, and they are a valuable resource for veterinarians and pet owners alike.

Regional Outlook

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region registered the highest revenue share in the market. The convenience and rapidity of point-of-care testing are making it a growing trend in the region. Rapid results of POCT for CRP testing can help with rapid diagnosis and therapy. The market in North America is anticipated to be driven by technological advancements that have improved CRP testing's accuracy, efficacy, and affordability. During the forecast period, it is predicted that the market in North America will be driven by the growth in the prevalence of inflammatory diseases unhealthy lifestyles, and the development of new testing kits and solutions for early detection of inflammatory ailments.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Danaher Corporation, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Laboratory Corporation of America Holdings, Randox Laboratories Limited, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Horiba, Ltd., Merck KGaA, and Zoetis, Inc.

Scope of the Study

Market Segments covered in the Report:

By Application

  • Cardiovascular Disease
  • Inflammatory Bowel Disease
  • Rheumatoid Arthritis
  • Diabetes
  • Others

By Assay Type

  • Immunoturbidimetric Assays
  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Chemiluminescence Immunoassay (CLIA)
  • Others

By End User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Laboratory Corporation of America Holdings
  • Randox Laboratories Limited
  • Thermo Fisher Scientific Inc.
  • Quest Diagnostics Incorporated
  • Horiba, Ltd.
  • Merck KGaA
  • Zoetis, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global C-reactive Protein Testing Market, by Application
    • 1.4.2 Global C-reactive Protein Testing Market, by Assay Type
    • 1.4.3 Global C-reactive Protein Testing Market, by End User
    • 1.4.4 Global C-reactive Protein Testing Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter's Five Force Analysis

Chapter 4. Global C-reactive Protein Testing Market by Application

  • 4.1 Global Cardiovascular Disease Market by Region
  • 4.2 Global Inflammatory Bowel Disease Market by Region
  • 4.3 Global Rheumatoid Arthritis Market by Region
  • 4.4 Global Diabetes Market by Region
  • 4.5 Global Others Market by Region

Chapter 5. Global C-reactive Protein Testing Market by Assay Type

  • 5.1 Global Immunoturbidimetric Assays Market by Region
  • 5.2 Global Enzyme-linked Immunosorbent Assay (ELISA) Market by Region
  • 5.3 Global Chemiluminescence Immunoassay (CLIA) Market by Region
  • 5.4 Global Others Market by Region

Chapter 6. Global C-reactive Protein Testing Market by End User

  • 6.1 Global Hospitals & Clinics Market by Region
  • 6.2 Global Diagnostic Laboratories Market by Region
  • 6.3 Global Others Market by Region

Chapter 7. Global C-reactive Protein Testing Market by Region

  • 7.1 North America C-reactive Protein Testing Market
    • 7.1.1 North America C-reactive Protein Testing Market by Application
      • 7.1.1.1 North America Cardiovascular Disease Market by Country
      • 7.1.1.2 North America Inflammatory Bowel Disease Market by Country
      • 7.1.1.3 North America Rheumatoid Arthritis Market by Country
      • 7.1.1.4 North America Diabetes Market by Country
      • 7.1.1.5 North America Others Market by Country
    • 7.1.2 North America C-reactive Protein Testing Market by Assay Type
      • 7.1.2.1 North America Immunoturbidimetric Assays Market by Country
      • 7.1.2.2 North America Enzyme-linked Immunosorbent Assay (ELISA) Market by Country
      • 7.1.2.3 North America Chemiluminescence Immunoassay (CLIA) Market by Country
      • 7.1.2.4 North America Others Market by Country
    • 7.1.3 North America C-reactive Protein Testing Market by End User
      • 7.1.3.1 North America Hospitals & Clinics Market by Country
      • 7.1.3.2 North America Diagnostic Laboratories Market by Country
      • 7.1.3.3 North America Others Market by Country
    • 7.1.4 North America C-reactive Protein Testing Market by Country
      • 7.1.4.1 US C-reactive Protein Testing Market
        • 7.1.4.1.1 US C-reactive Protein Testing Market by Application
        • 7.1.4.1.2 US C-reactive Protein Testing Market by Assay Type
        • 7.1.4.1.3 US C-reactive Protein Testing Market by End User
      • 7.1.4.2 Canada C-reactive Protein Testing Market
        • 7.1.4.2.1 Canada C-reactive Protein Testing Market by Application
        • 7.1.4.2.2 Canada C-reactive Protein Testing Market by Assay Type
        • 7.1.4.2.3 Canada C-reactive Protein Testing Market by End User
      • 7.1.4.3 Mexico C-reactive Protein Testing Market
        • 7.1.4.3.1 Mexico C-reactive Protein Testing Market by Application
        • 7.1.4.3.2 Mexico C-reactive Protein Testing Market by Assay Type
        • 7.1.4.3.3 Mexico C-reactive Protein Testing Market by End User
      • 7.1.4.4 Rest of North America C-reactive Protein Testing Market
        • 7.1.4.4.1 Rest of North America C-reactive Protein Testing Market by Application
        • 7.1.4.4.2 Rest of North America C-reactive Protein Testing Market by Assay Type
        • 7.1.4.4.3 Rest of North America C-reactive Protein Testing Market by End User
  • 7.2 Europe C-reactive Protein Testing Market
    • 7.2.1 Europe C-reactive Protein Testing Market by Application
      • 7.2.1.1 Europe Cardiovascular Disease Market by Country
      • 7.2.1.2 Europe Inflammatory Bowel Disease Market by Country
      • 7.2.1.3 Europe Rheumatoid Arthritis Market by Country
      • 7.2.1.4 Europe Diabetes Market by Country
      • 7.2.1.5 Europe Others Market by Country
    • 7.2.2 Europe C-reactive Protein Testing Market by Assay Type
      • 7.2.2.1 Europe Immunoturbidimetric Assays Market by Country
      • 7.2.2.2 Europe Enzyme-linked Immunosorbent Assay (ELISA) Market by Country
      • 7.2.2.3 Europe Chemiluminescence Immunoassay (CLIA) Market by Country
      • 7.2.2.4 Europe Others Market by Country
    • 7.2.3 Europe C-reactive Protein Testing Market by End User
      • 7.2.3.1 Europe Hospitals & Clinics Market by Country
      • 7.2.3.2 Europe Diagnostic Laboratories Market by Country
      • 7.2.3.3 Europe Others Market by Country
    • 7.2.4 Europe C-reactive Protein Testing Market by Country
      • 7.2.4.1 Germany C-reactive Protein Testing Market
        • 7.2.4.1.1 Germany C-reactive Protein Testing Market by Application
        • 7.2.4.1.2 Germany C-reactive Protein Testing Market by Assay Type
        • 7.2.4.1.3 Germany C-reactive Protein Testing Market by End User
      • 7.2.4.2 UK C-reactive Protein Testing Market
        • 7.2.4.2.1 UK C-reactive Protein Testing Market by Application
        • 7.2.4.2.2 UK C-reactive Protein Testing Market by Assay Type
        • 7.2.4.2.3 UK C-reactive Protein Testing Market by End User
      • 7.2.4.3 France C-reactive Protein Testing Market
        • 7.2.4.3.1 France C-reactive Protein Testing Market by Application
        • 7.2.4.3.2 France C-reactive Protein Testing Market by Assay Type
        • 7.2.4.3.3 France C-reactive Protein Testing Market by End User
      • 7.2.4.4 Russia C-reactive Protein Testing Market
        • 7.2.4.4.1 Russia C-reactive Protein Testing Market by Application
        • 7.2.4.4.2 Russia C-reactive Protein Testing Market by Assay Type
        • 7.2.4.4.3 Russia C-reactive Protein Testing Market by End User
      • 7.2.4.5 Spain C-reactive Protein Testing Market
        • 7.2.4.5.1 Spain C-reactive Protein Testing Market by Application
        • 7.2.4.5.2 Spain C-reactive Protein Testing Market by Assay Type
        • 7.2.4.5.3 Spain C-reactive Protein Testing Market by End User
      • 7.2.4.6 Italy C-reactive Protein Testing Market
        • 7.2.4.6.1 Italy C-reactive Protein Testing Market by Application
        • 7.2.4.6.2 Italy C-reactive Protein Testing Market by Assay Type
        • 7.2.4.6.3 Italy C-reactive Protein Testing Market by End User
      • 7.2.4.7 Rest of Europe C-reactive Protein Testing Market
        • 7.2.4.7.1 Rest of Europe C-reactive Protein Testing Market by Application
        • 7.2.4.7.2 Rest of Europe C-reactive Protein Testing Market by Assay Type
        • 7.2.4.7.3 Rest of Europe C-reactive Protein Testing Market by End User
  • 7.3 Asia Pacific C-reactive Protein Testing Market
    • 7.3.1 Asia Pacific C-reactive Protein Testing Market by Application
      • 7.3.1.1 Asia Pacific Cardiovascular Disease Market by Country
      • 7.3.1.2 Asia Pacific Inflammatory Bowel Disease Market by Country
      • 7.3.1.3 Asia Pacific Rheumatoid Arthritis Market by Country
      • 7.3.1.4 Asia Pacific Diabetes Market by Country
      • 7.3.1.5 Asia Pacific Others Market by Country
    • 7.3.2 Asia Pacific C-reactive Protein Testing Market by Assay Type
      • 7.3.2.1 Asia Pacific Immunoturbidimetric Assays Market by Country
      • 7.3.2.2 Asia Pacific Enzyme-linked Immunosorbent Assay (ELISA) Market by Country
      • 7.3.2.3 Asia Pacific Chemiluminescence Immunoassay (CLIA) Market by Country
      • 7.3.2.4 Asia Pacific Others Market by Country
    • 7.3.3 Asia Pacific C-reactive Protein Testing Market by End User
      • 7.3.3.1 Asia Pacific Hospitals & Clinics Market by Country
      • 7.3.3.2 Asia Pacific Diagnostic Laboratories Market by Country
      • 7.3.3.3 Asia Pacific Others Market by Country
    • 7.3.4 Asia Pacific C-reactive Protein Testing Market by Country
      • 7.3.4.1 China C-reactive Protein Testing Market
        • 7.3.4.1.1 China C-reactive Protein Testing Market by Application
        • 7.3.4.1.2 China C-reactive Protein Testing Market by Assay Type
        • 7.3.4.1.3 China C-reactive Protein Testing Market by End User
      • 7.3.4.2 Japan C-reactive Protein Testing Market
        • 7.3.4.2.1 Japan C-reactive Protein Testing Market by Application
        • 7.3.4.2.2 Japan C-reactive Protein Testing Market by Assay Type
        • 7.3.4.2.3 Japan C-reactive Protein Testing Market by End User
      • 7.3.4.3 India C-reactive Protein Testing Market
        • 7.3.4.3.1 India C-reactive Protein Testing Market by Application
        • 7.3.4.3.2 India C-reactive Protein Testing Market by Assay Type
        • 7.3.4.3.3 India C-reactive Protein Testing Market by End User
      • 7.3.4.4 South Korea C-reactive Protein Testing Market
        • 7.3.4.4.1 South Korea C-reactive Protein Testing Market by Application
        • 7.3.4.4.2 South Korea C-reactive Protein Testing Market by Assay Type
        • 7.3.4.4.3 South Korea C-reactive Protein Testing Market by End User
      • 7.3.4.5 Singapore C-reactive Protein Testing Market
        • 7.3.4.5.1 Singapore C-reactive Protein Testing Market by Application
        • 7.3.4.5.2 Singapore C-reactive Protein Testing Market by Assay Type
        • 7.3.4.5.3 Singapore C-reactive Protein Testing Market by End User
      • 7.3.4.6 Malaysia C-reactive Protein Testing Market
        • 7.3.4.6.1 Malaysia C-reactive Protein Testing Market by Application
        • 7.3.4.6.2 Malaysia C-reactive Protein Testing Market by Assay Type
        • 7.3.4.6.3 Malaysia C-reactive Protein Testing Market by End User
      • 7.3.4.7 Rest of Asia Pacific C-reactive Protein Testing Market
        • 7.3.4.7.1 Rest of Asia Pacific C-reactive Protein Testing Market by Application
        • 7.3.4.7.2 Rest of Asia Pacific C-reactive Protein Testing Market by Assay Type
        • 7.3.4.7.3 Rest of Asia Pacific C-reactive Protein Testing Market by End User
  • 7.4 LAMEA C-reactive Protein Testing Market
    • 7.4.1 LAMEA C-reactive Protein Testing Market by Application
      • 7.4.1.1 LAMEA Cardiovascular Disease Market by Country
      • 7.4.1.2 LAMEA Inflammatory Bowel Disease Market by Country
      • 7.4.1.3 LAMEA Rheumatoid Arthritis Market by Country
      • 7.4.1.4 LAMEA Diabetes Market by Country
      • 7.4.1.5 LAMEA Others Market by Country
    • 7.4.2 LAMEA C-reactive Protein Testing Market by Assay Type
      • 7.4.2.1 LAMEA Immunoturbidimetric Assays Market by Country
      • 7.4.2.2 LAMEA Enzyme-linked Immunosorbent Assay (ELISA) Market by Country
      • 7.4.2.3 LAMEA Chemiluminescence Immunoassay (CLIA) Market by Country
      • 7.4.2.4 LAMEA Others Market by Country
    • 7.4.3 LAMEA C-reactive Protein Testing Market by End User
      • 7.4.3.1 LAMEA Hospitals & Clinics Market by Country
      • 7.4.3.2 LAMEA Diagnostic Laboratories Market by Country
      • 7.4.3.3 LAMEA Others Market by Country
    • 7.4.4 LAMEA C-reactive Protein Testing Market by Country
      • 7.4.4.1 Brazil C-reactive Protein Testing Market
        • 7.4.4.1.1 Brazil C-reactive Protein Testing Market by Application
        • 7.4.4.1.2 Brazil C-reactive Protein Testing Market by Assay Type
        • 7.4.4.1.3 Brazil C-reactive Protein Testing Market by End User
      • 7.4.4.2 Argentina C-reactive Protein Testing Market
        • 7.4.4.2.1 Argentina C-reactive Protein Testing Market by Application
        • 7.4.4.2.2 Argentina C-reactive Protein Testing Market by Assay Type
        • 7.4.4.2.3 Argentina C-reactive Protein Testing Market by End User
      • 7.4.4.3 UAE C-reactive Protein Testing Market
        • 7.4.4.3.1 UAE C-reactive Protein Testing Market by Application
        • 7.4.4.3.2 UAE C-reactive Protein Testing Market by Assay Type
        • 7.4.4.3.3 UAE C-reactive Protein Testing Market by End User
      • 7.4.4.4 Saudi Arabia C-reactive Protein Testing Market
        • 7.4.4.4.1 Saudi Arabia C-reactive Protein Testing Market by Application
        • 7.4.4.4.2 Saudi Arabia C-reactive Protein Testing Market by Assay Type
        • 7.4.4.4.3 Saudi Arabia C-reactive Protein Testing Market by End User
      • 7.4.4.5 South Africa C-reactive Protein Testing Market
        • 7.4.4.5.1 South Africa C-reactive Protein Testing Market by Application
        • 7.4.4.5.2 South Africa C-reactive Protein Testing Market by Assay Type
        • 7.4.4.5.3 South Africa C-reactive Protein Testing Market by End User
      • 7.4.4.6 Nigeria C-reactive Protein Testing Market
        • 7.4.4.6.1 Nigeria C-reactive Protein Testing Market by Application
        • 7.4.4.6.2 Nigeria C-reactive Protein Testing Market by Assay Type
        • 7.4.4.6.3 Nigeria C-reactive Protein Testing Market by End User
      • 7.4.4.7 Rest of LAMEA C-reactive Protein Testing Market
        • 7.4.4.7.1 Rest of LAMEA C-reactive Protein Testing Market by Application
        • 7.4.4.7.2 Rest of LAMEA C-reactive Protein Testing Market by Assay Type
        • 7.4.4.7.3 Rest of LAMEA C-reactive Protein Testing Market by End User

Chapter 8. Company Profiles

  • 8.1 Danaher Corporation
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 SWOT Analysis
  • 8.2 F. Hoffmann-La Roche Ltd.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 SWOT Analysis
  • 8.3 Abbott Laboratories
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 SWOT Analysis
  • 8.4 Thermo Fisher Scientific, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expenses
    • 8.4.5 SWOT Analysis
  • 8.5 Horiba Ltd.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Regional & Segmental Analysis
    • 8.5.4 Research & Development Expenses
    • 8.5.5 SWOT Analysis
  • 8.6 Randox Laboratories Limited
    • 8.6.1 Company Overview
    • 8.6.2 SWOT Analysis
  • 8.7 Zoetis, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Regional Analysis
    • 8.7.4 Research & Development Expense
    • 8.7.5 SWOT Analysis
  • 8.8 Quest Diagnostics Incorporated
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental Analysis
    • 8.8.4 SWOT Analysis
  • 8.9 Laboratory Corporation of America Holdings
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental Analysis
    • 8.9.4 SWOT Analysis
  • 8.10. Merck KGaA
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Segmental and Regional Analysis
    • 8.10.4 Research & Development Expense
    • 8.10.5 SWOT Analysis

Chapter 9. Winning Imperative for C-Reactive Protein Testing Market